Artificial intelligence promises smarter, more resilient pharmaceutical supply chains. Yet discussions at Airfreight Pharma 2026 in Athens highlighted a fundamental challenge: technology is advancing faster than the industry’s ability to share, interpret and act on data.
Pharmaceutical airfreight has never had access to more information. Temperature monitoring, shipment tracking, predictive analytics and increasingly sophisticated digital tools are creating new opportunities to understand and manage supply-chain risks.
But more data does not automatically mean better decisions.
At Airfreight Pharma 2026, hosted in Athens with the participation of the Cool Chain Association (CCA), industry stakeholders explored how artificial intelligence, data transparency and operational expertise could improve product protection and supply-chain resilience.
A recurring theme was clear: the real challenge is not simply collecting data, but turning it into trusted, actionable intelligence across the entire supply chain.
Pharmaceutical shipments pass through multiple organisations, each responsible for a different stage of the journey.
Manufacturers, freight forwarders, airlines, ground handlers and transport providers all generate valuable operational data. Yet that information is often held in separate systems, governed by different commercial agreements and subject to varying data protection requirements.
Data governance and security are essential, particularly in a highly regulated industry. However, these requirements can also make it difficult to share the information needed to develop a complete picture of shipment performance.
The result is a paradox: the industry is investing heavily in visibility, while the information required to make end-to-end decisions may remain fragmented.
The discussions in Athens highlighted the need to move beyond simply increasing the volume of available data towards establishing greater clarity over what information is needed, who can access it and how it can be used responsibly.
Greater transparency does not necessarily mean sharing everything. It means sharing the right information, with the right stakeholders, at the right time.
Artificial intelligence and digital simulation offer significant potential for pharmaceutical logistics.
During the event, participants explored how digital twins could help assess operational variables, simulate disruptions and understand how different conditions might affect temperature-controlled shipments.
Such capabilities could support more informed lane qualification, improved contingency planning and better identification of potential failure points.
However, the quality of any AI-driven insight depends on the reliability and relevance of the underlying data.
A temperature reading without sufficient operational context may not explain what happened to a shipment, why it happened or what action should follow.
Product stability, packaging performance, route conditions and handling procedures must all be considered before interpreting the significance of an event.
The discussions also reinforced the importance of human judgement.
When a shipment is delayed on the tarmac or an unexpected operational disruption occurs, the time available to intervene may be measured in minutes.
Data can alert stakeholders to a developing risk, but trained personnel must understand the situation, assess the options and act.
This makes continued investment in people, training and operational decision-making just as important as investment in technology.
For pharmaceutical manufacturers, visibility is valuable, but it is not the ultimate objective.
The priority is protecting product integrity and ensuring that medicines reach patients safely.
During the cool-corridor discussions, participants repeatedly emphasised that confidence in a logistics process must be supported by evidence.
Temperature records, qualification studies, operational performance data, deviation histories and demonstrated risk controls all contribute to that confidence.
AI and analytics can help organisations interpret this information and identify opportunities for improvement. But technology cannot replace the need for reliable evidence that a process performs consistently.
This distinction becomes particularly important when evaluating temperature-controlled corridors.
A route that performs well under one set of conditions may behave differently during another season, with different packaging or when operational arrangements change.
Understanding these variables requires more than an isolated dataset. It requires collaboration between the organisations responsible for each stage of the journey.
The pharmaceutical logistics industry has made considerable progress in monitoring technology, digitalisation and data collection.
The next opportunity lies in connecting those capabilities more effectively.
This does not require organisations to abandon commercial confidentiality or compromise data protection. It requires a shared understanding of which information is essential for product protection, how it should be governed and how it can support collective learning.
Through its community of stakeholders across the temperature-controlled supply chain, the Cool Chain Association has an important role in encouraging these conversations.
Better collaboration around data could help the industry identify recurring operational weaknesses, improve procedures, strengthen lane qualification and reduce avoidable inefficiencies.
It could also help organisations move from reacting to individual shipment problems towards understanding and addressing their underlying causes.
That is where the potential of AI becomes particularly valuable: not simply predicting what might go wrong, but helping the industry learn how to prevent it.
The discussions at Airfreight Pharma 2026 demonstrated that artificial intelligence will continue to influence the future of pharmaceutical logistics.
But successful adoption will require more than investment in algorithms, platforms and monitoring devices.
It will require high-quality data, responsible governance, transparent collaboration and continued investment in the people who interpret information and make critical decisions.
The industry’s opportunity is not simply to become more data-driven. It is to become more evidence-driven, more collaborative and ultimately more predictable.
Because in pharmaceutical logistics, better decisions are not just about efficiency.
They are about protecting products, reducing risk and maintaining the trust of the patients who depend on them.
Working together to improve the temperature-sensitive supply chain to reduce food loss and waste in the perishables sector as well as benefiting the pharma community.
Registered Address
9 Rue de Siegelbach
L-5361 Schrassig
Grand Dutchy of Luxembourg
Subscribe to the Cool Chain Association newsletter for the latest news and updates
You have successfully joined our subscriber list.
Cool Chain Association
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to